R1 RCM [NASDAQ: RCM] Stock Not Affected by Recent Price Drop, New Price Target of $19.56 Makes it an Attractive Investment Choice
May 27, 2023
Trending News ☀️
The company is dedicated to improving the financial health of providers through their suite of revenue cycle management services. Despite the recent downward trend in the stock market, R1 RCM ($NASDAQ:RCM) has maintained a steady price target of $19.56, making it an attractive investment option for investors. With a strong financial background and a focus on providing the highest quality services, R1 RCM is well-positioned to weather any potential market downturns and still remain an attractive investment choice. Furthermore, with a low price target, investors can purchase shares in the company at a relatively low cost while still reaping the potential benefits of their long-term investments.
Despite the recent downward trend, the company is still well-positioned to remain profitable and provide value to shareholders in the long-term. With a low price target and strong financials, this company is an ideal choice for investors looking to secure their finances and gain exposure to the healthcare services industry.
Price History
Friday was a good news day for NASDAQ: RCM investors, as R1 RCM Inc. stock opened at $15.9 and closed at $16.1, which was 1.5% up from last closing price of $15.8. Despite the recent market price drops, R1 RCM Inc. is solidly standing its ground and projecting a healthy outlook. The current stock reflects good earning potential and potential gains for the future, making it an ideal choice for those looking for an opportunity to make a smart long-term investment in this sector. Given the current market conditions, R1 RCM Inc. stock appears to be unaffected by price drops, and with the new price target of $19.56, it remains a viable option for those looking to invest with a long-term view in mind. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for R1 Rcm. More…
| Total Revenues | Net Income | Net Margin |
| 1.97k | -86.7 | 4.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for R1 Rcm. More…
| Operations | Investing | Financing |
| 13.9 | -965.1 | 933.8 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for R1 Rcm. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 5.07k | 2.35k | 6.5 |
Key Ratios Snapshot
Some of the financial key ratios for R1 Rcm are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 16.9% | 17.0% | -0.3% |
| FCF Margin | ROE | ROA |
| -4.7% | -0.1% | -0.1% |
Analysis
At GoodWhale, we have conducted an in-depth analysis of R1 RCM‘s fundamentals. Our Risk Rating for this investment suggests that it is a high risk investment from both a financial and business perspective. We have identified 3 risk warnings in R1 RCM’s income sheet, balance sheet, and cashflow statement. These potential risks should be taken into account before making any decision to invest in the company. To get an in-depth understanding of these risk warnings, become a registered user on our platform. More…
Peers
Its competitors include MobileSmith Inc, Thomson Medical Group Ltd, and Ping An Healthcare And Technology Co Ltd.
– MobileSmith Inc ($SGX:A50)
Thomson Medical Group Ltd is a Singapore-based healthcare group. The Group’s segments include Healthcare Services, which comprises hospital, clinics and health insurance businesses; and Healthcare Equipment and Supplies, which comprises medical equipment and supplies businesses. The Company’s healthcare services segment includes Thomson Medical Centre, Thomson Women’s Clinic, The Children’s Clinic, Camden Medical Centre, Gleneagles Hong Kong Hospital, KK Women’s and Children’s Hospital, Mount Elizabeth Novena Hospital and Parkway East Hospital. The Company’s healthcare equipment and supplies segment includes Thomson Medisave, Thomson Chinese Medicine and Thomson Wellth Clinic.
– Thomson Medical Group Ltd ($SEHK:01833)
Ping An Healthcare and Technology Co Ltd is a holding company that provides technology-enabled healthcare services in China. The company operates an online platform that offers medical and health services, including disease screening, health management, and telemedicine consultation. It also provides online pharmacy services. The company was founded in 2014 and is headquartered in Shenzhen, China.
Summary
R1 RCM Inc. NASDAQ: RCM is an attractive stock option for investors seeking a good return on their investments. Despite this, analysts have recommended RCM as a solid choice due to its strong financials and potential for long-term growth. Overall, RCM is an attractive stock option for investors looking for a rewarding investment.
